MAA
CELG

Mraz Amerine & Associates’s Celgene Corp CELG Stock Holding History

Mraz Amerine & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,925
Closed -$290K – 176
2019
Q3 		$290K Sell
2,925
-175
-6% -$16.6K 0.09% 120
2019
Q2 		$287K Hold
3,100
– – 0.09% 126
2019
Q1 		$292K Sell
3,100
-300
-9% -$26.2K 0.09% 125
2018
Q4 		$218K Hold
3,400
– – 0.07% 136
2018
Q3 		$304K Hold
3,400
– – 0.09% 128
2018
Q2 		$270K Hold
3,400
– – 0.08% 132
2018
Q1 		$303K Buy
+3,400
New +$326K 0.1% 116

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Mraz Amerine & Associates's CELG Position: Q4 2019 in Review

Mraz Amerine & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,925 shares — an estimated $290K sold.

Mraz Amerine & Associates first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $304K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mraz Amerine & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mraz Amerine & Associates sold 2,925 Celgene Corp shares in Q4 2019, an estimated $290K.
  • Mraz Amerine & Associates first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Mraz Amerine & Associates's Celgene Corp position peaked at $304K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mraz Amerine & Associates's 13F filing for Q4 2019, filed 10 Feb 2020.